K&L Gates Health Care Triage
K&L Gates
Triage: Rapid Legal Lessons for Busy Health Care Professionals has been created by K&L Gates to convey information about developments in health law through short podcasts. If you work in the health care industry, you have grown accustomed to frequent changes in laws and regulations. On some days, it may seem like an insurmountable task to keep up with every change, especially as a new presidential administration and new policies take shape. The K&L Gates Health Care practice will regularly create Triage podcasts to help you learn about the latest developments in health law. Our lawyers will identify the most important changes and analyze the impact of these changes on our clients.
Categorias: Finanzas
Escuchar el último episodio:
In this two-part Triage series, Gina Bertolini, Stephen Page, and Sarah Staples-Carlton discuss an old health care regulatory doctrine that has new relevance in a post-COVID world, where the delivery of care via telemedicine and other remote models has become heavily adopted: Corporate Practice of Medicine, or “CPOM.” As more and more health care companies look for innovative ways to deliver healthcare, it can be easy for seasoned healthcare professionals and newcomers alike to discount or dismiss CPOM. While on its face it is a straightforward prohibition, it is important to understand the doctrine’s underlying philosophy and to appreciate its complexity, particularly how it varies from state to state. This is particularly the case where telehealth has become an established method for the delivery of care, and many new companies are entering the health care space. As health care entities, health IT solutions providers, and other companies seek to deliver care in one or more states, there are many health care regulatory considerations to consider, but CPOM should be at the top of the list.
In part one of this series, Gina Bertolini, Stephen Page, and Sarah Staples-Carlton offer a brief primer on CPOM, answer some practical questions about its impact, and elaborate on its present-day relevance for health care providers and other companies.
Episodios anteriores
-
181 - Corporate Practice of Medicine: New Relevance in a Changing World Tue, 09 Apr 2024 - 0h
-
180 - Health System Cybersecurity Risks: Part Two Mon, 01 Apr 2024 - 0h
-
179 - Health System Cybersecurity Risks: Part One Tue, 26 Mar 2024 - 0h
-
178 - Highlights from FDA Regulatory Developments in Clinical Trials: 2023 Recap and 2024 Forecast Tue, 05 Mar 2024 - 0h
-
177 - FDA Issues Guidance on Informed Consent for IRBs, Clinical Investigators, and Sponsors Thu, 12 Oct 2023 - 0h
-
176 - Ensuring Continuity of Care Following a Cyberattack: ARPA-H Launches Project to Enhance Cybersecurity Tools for Health Care Organizations Fri, 08 Sep 2023 - 0h
-
175 - Unpacking CMS's Proposed Rule for Correcting Underpayments for 340B Drug Reimbursement Tue, 22 Aug 2023 - 0h
-
174 - The End of Continuous Medicaid Enrollment—What Health Systems Should Know Wed, 12 Jul 2023 - 0h
-
173 - Value-Based Lessons Learned: Two Years Later, How Have Providers Utilized New AKS and Stark Flexibilities? Tue, 27 Jun 2023 - 0h
-
172 - Highlights for Research Institutions and Sponsors in FDA's Recent Draft Guidance on Decentralized Clinical Trials Thu, 01 Jun 2023 - 0h
-
171 - 2022 Health Care Employment Law Year in Review Wed, 29 Mar 2023 - 0h
-
170 - Rural Emergency Hospitals — Transformative Change or Limited Impact? Tue, 21 Mar 2023 - 0h
-
169 - Stark Law and the Anti-Kickback Statute Under the False Claims Act Thu, 12 Jan 2023 - 0h
-
168 - Recent Developments to the 340B Drug Pricing Program Thu, 15 Dec 2022 - 0h
-
167 - The Information Blocking Rule's "Glide Path" - Compliance with the Information Blocking Rule After the Limitation on the Scope of EHI is Lifted Tue, 29 Nov 2022 - 0h
-
166 - New Data Available Under the Hospital Price Transparency Rule Mon, 14 Nov 2022 - 0h
-
165 - Issue-Spotting Hospital Activities that May Trigger FDA Regulatory Oversight Mon, 26 Sep 2022 - 0h
-
164 - Cybersecurity & HIPAA: NIST’s Practical Guidance Updates for Covered Entities and Business Associates Mon, 29 Aug 2022 - 0h
-
163 - Genesis Healthcare and the 340B Program Patient Definition Tue, 09 Aug 2022 - 0h
-
162 - Medicare Advantage False Claims Act Developments Tue, 02 Aug 2022 - 0h
-
161 - Hospitals, Physician Practices, and Labs – Are You Ready to Report Private Payor Rates for Laboratory Tests? Tue, 05 Jul 2022 - 0h
-
160 - The Drive to Align ESG and Health Equity Priorities With Medicare Reimbursement Models Tue, 07 Jun 2022 - 0h
-
159 - Regulatory, Contractual, and Governance Considerations for Data Transactions Tue, 10 May 2022 - 0h
-
158 - Medical Laboratories Under the Microscope Fri, 22 Apr 2022 - 0h
-
157 - Navigating the Independent Dispute Resolution Process Under the No Surprises Act Wed, 30 Mar 2022 - 0h
-
156 - 2021 Health Care Employment Law Year in Review and a Look Forward Wed, 23 Mar 2022 - 0h
-
155 - Medicare Reimbursement for Community Hospital Residency Programs Mon, 31 Jan 2022 - 0h
-
154 - Data Security Breaches in the Health Care Sector Thu, 20 Jan 2022 - 0h
-
153 - What Health Care Providers Should Expect in an FDA Inspection Thu, 28 Oct 2021 - 0h
-
152 - An Update on the CMS Hospital Price Transparency Rule Thu, 21 Oct 2021 - 0h
-
151 - FTC Reminds Vendors of Personal Health Records of Breach Rule Obligations Thu, 07 Oct 2021 - 0h
-
150 - No Surprises: New Balance Billing Regulations for Health Care Providers Thu, 16 Sep 2021 - 0h
-
149 - CMS’s Proposal for New Remote Therapeutic Monitoring Codes under the 2022 Medicare Physician Fee Schedule Thu, 19 Aug 2021 - 0h
-
148 - Key Considerations for Officers and Directors of Distressed Companies Tue, 17 Aug 2021 - 0h
-
147 - Cybersecurity Risk in the Health Care Industry Mon, 09 Aug 2021 - 0h
-
146 - When Regulatory Review is Necessary: Clinical Research vs. Quality Initiatives Thu, 15 Jul 2021 - 0h
-
145 - OFCCP Enforcement in the Health Care Space Thu, 08 Jul 2021 - 0h
-
144 - Understanding OIG and CMS Audits Thu, 10 Jun 2021 - 0h
-
143 - The Power of Health Care: Renewable Energy Transactions from the Health Care Perspective Thu, 03 Jun 2021 - 0h
-
142 - Health Care Audit and Reimbursement Trends and Challenges Thu, 29 Apr 2021 - 0h
-
141 - Long-Term Care: Exploring Lessons from the Past Year and Current Topics Facing the Industry Thu, 22 Apr 2021 - 0h
-
140 - Health Care Transactions Trends in 2021 and Beyond Thu, 08 Apr 2021 - 0h
-
139 - 340B Drug Pricing Program 2021 Outlook Fri, 19 Mar 2021 - 0h
-
138 - Health Care and Employment Law: 2020 Year in Review and Looking Ahead Mon, 15 Mar 2021 - 0h
-
137 - What to Expect in Health Care in 2021 Fri, 26 Feb 2021 - 0h
-
136 - What AMCs May Expect in Health Care Policy Priorities from the New Congress and the Biden Administration Thu, 18 Feb 2021 - 0h
-
135 - Information Blocking Considerations for Providers Under the CMS Interoperability and Patient Access Final Rule Thu, 17 Dec 2020 - 0h
-
134 - Recent District Court Decision Highlights the Importance of Adequate Behavioral Health Claims Processing Guidelines for ERISA Plans Fri, 11 Dec 2020 - 0h
-
133 - 340B Update: HRSA Moves Forward with 340B ADR Rule as Covered Entities Challenge Contract Pharmacy Actions Thu, 03 Dec 2020 - 0h
-
132 - COVID-19: Frontline University Perspective on the Pandemic’s Disruption to Ongoing Research, and Public Policy Projections for a Federal Response Mon, 23 Nov 2020 - 0h